Cytek Biosciences (CTKB)

Common Shares
Sell: $4.91|Buy: $5.01|Change: 0.13 (-2.57%)

Company profile

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. ItsFSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Address





Sector 

Healthcare


Previous key dates

NameKey Date
Piper Sandler 37th Annual Healthcare Conference2025-12-03T09:00:00
Stephens NASH25 Investment Conference2025-11-19T12:00:00
Cytek Biosciences Inc Third Quarter Earnings Conference Call for 20252025-11-05T16:30:00
Cytek Biosciences Inc Third Quarter Earnings Result for 20252025-11-05T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T10:00:00
UBS Precision Medicine Summit in Dana Point, CA2025-08-14T08:15:00
Cytek Biosciences Inc Second Quarter Earnings Conference Call for 20252025-08-06T16:30:00
Cytek Biosciences Inc Second Quarter Earnings Result for 20252025-08-06T00:00:00
Cytek Biosciences Inc Annual General Meeting for 20252025-06-18T11:00:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-11T14:40:00
Cytek Biosciences Inc First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
Cytek Biosciences Inc First Quarter Earnings Results for 20252025-05-08T00:00:00
Leerink Partners Global Healthcare Conference2025-03-10T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-05T10:30:00
Raymond James 46th Annual Institutional Investors Conference2025-03-03T15:25:00
Cytek Biosciences Inc Annual Report for 20242025-02-28T00:00:00
Cytek Biosciences Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T16:30:00
Cytek Biosciences Inc Fourth Quarter Earnings Results for 20242025-02-27T00:00:00
BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference2025-02-11T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-16T11:15:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.